Average Co-Inventor Count = 12.24
ph-index = 7
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Vertex Pharmaceuticals, Inc. (23 from 1,152 patents)
2. Theravance, Inc. (2 from 386 patents)
3. Theravance Biopharma R&d Ip, LLC (2 from 262 patents)
27 patents:
1. 12421251 - Cystic fibrosis transmembrane conductance regulator modulating agents
2. 12319693 - Crystalline forms of CFTR modulators
3. 12168009 - Modulators of cystic fibrosis transmembrane conductance regulator
4. 12122788 - Process of making CFTR modulators
5. 11873300 - Crystalline forms of CFTR modulators
6. 11866450 - Modulators of Cystic Fibrosis Transmembrane Conductance regulator, pharmaceutical compositions, methods of treatment, and process for making the modulators
7. 11591350 - Modulators of cystic fibrosis transmembrane conductance regulator
8. 11584761 - Process of making CFTR modulators
9. 11426407 - Modulators of cystic fibrosis transmembrane conductance regulator
10. 11186566 - Modulator of cystic fibrosis transmembrane conductance regulator, pharmaceutical compositions, methods of treatment, and process for making the modulator
11. 11066417 - Modulators of cystic fibrosis transmembrane conductance regulator, pharmaceutical compositions, methods of treatment, and process for making the modulators
12. 10758534 - Modulators of cystic fibrosis transmembrane conductance regulator
13. 10738030 - Modulators of cystic fibrosis transmembrane conductance regulator
14. 10570115 - Modulator of cystic fibrosis transmembrane conductance regulator, pharmaceutical compositions, methods of treatment, and process for making the modulator
15. 10385070 - Chroman-spirocyclic piperidine amides as modulators of ion channels